Hardback / gebonden
|
Engels
€ 32,95
- Vanaf €15,- geen verzendkosten.
- 30 dagen ruiltermijn voor fysieke producten
Omschrijving
Antibiotics are powerful drugs that can prevent and treat infections, but they are becoming less effective as a result of drug resistance. Superbugs describes this growing global threat, the systematic failures that have led to it, and solutions that governments, industries, and public health specialists can adopt.
[L]ucid and thoughtful… Superbugs provides a set of policy prescriptions, framed in pragmatic terms meant to motivate self-interested politicians.
An immensely readable description of the challenges that encourage overuse of antibiotics and discourage new drug development…Superbugs is a worthy exposition of the challenges we will have to surmount to incentivize more responsible antibiotic use until we discover new ways of dealing with infections.
As antibiotics become increasingly ineffective, modern medicine faces a global threat. Can we do anything to stop it? That’s the question posed by the book Superbugs: An Arms Race against Bacteria. [The] authors look at the rise of drug resistance, and their research is sobering.
Excellent.
Jim O’Neill helped take the issue of antimicrobial resistance from the science lab to the global stage. He and coauthors Anthony McDonnell and William Hall impart a compelling story about the battle against what could become a mass killer of humanity.
Addressing antimicrobial resistance requires the kind of thoughtful yet action-oriented analysis that this vitally important book provides. The messages in Superbugs should be heeded by individuals, government officials, and policymakers around the world.
With superb insight into one of the greatest health threats to humankind, Superbugs highlights the need for an integrated, multifaceted approach to treating drug-resistant infections. This riveting book makes a compelling case for action.
William Hall, a public policy professional, served as Senior Policy Advisor for the Review on Antimicrobial Resistance. Anthony McDonnell is Senior Health Economist, Nuffield Department of Medicine, University of Oxford, and was Head of Economic Research for the Review on Antimicrobial Resistance. Jim O’Neill, an internationally recognized economist, served as Chair of the Review on Antimicrobial Resistance.
[L]ucid and thoughtful… Superbugs provides a set of policy prescriptions, framed in pragmatic terms meant to motivate self-interested politicians.
An immensely readable description of the challenges that encourage overuse of antibiotics and discourage new drug development…Superbugs is a worthy exposition of the challenges we will have to surmount to incentivize more responsible antibiotic use until we discover new ways of dealing with infections.
As antibiotics become increasingly ineffective, modern medicine faces a global threat. Can we do anything to stop it? That’s the question posed by the book Superbugs: An Arms Race against Bacteria. [The] authors look at the rise of drug resistance, and their research is sobering.
Excellent.
Jim O’Neill helped take the issue of antimicrobial resistance from the science lab to the global stage. He and coauthors Anthony McDonnell and William Hall impart a compelling story about the battle against what could become a mass killer of humanity.
Addressing antimicrobial resistance requires the kind of thoughtful yet action-oriented analysis that this vitally important book provides. The messages in Superbugs should be heeded by individuals, government officials, and policymakers around the world.
With superb insight into one of the greatest health threats to humankind, Superbugs highlights the need for an integrated, multifaceted approach to treating drug-resistant infections. This riveting book makes a compelling case for action.
William Hall, a public policy professional, served as Senior Policy Advisor for the Review on Antimicrobial Resistance. Anthony McDonnell is Senior Health Economist, Nuffield Department of Medicine, University of Oxford, and was Head of Economic Research for the Review on Antimicrobial Resistance. Jim O’Neill, an internationally recognized economist, served as Chair of the Review on Antimicrobial Resistance.